Wells Fargo
ANVS icon

Wells Fargo’s Annovis Bio ANVS Stock Holding History

Wells Fargo’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56.4K Buy
30,307
+16,000
+112% +$31.1K ﹤0.01% 5686
2026
Q1 		$31.9K Hold
14,307
– – ﹤0.01% 5602
2025
Q4 		$49.5K Buy
14,307
+4,561
+47% +$13.7K ﹤0.01% 5583
2025
Q3 		$20.2K Hold
9,746
– – ﹤0.01% 5800
2025
Q2 		$21.1K Hold
9,746
– – ﹤0.01% 5776
2025
Q1 		$14.6K Hold
9,746
– – ﹤0.01% 5792
2024
Q4 		$49K Hold
9,746
– – ﹤0.01% 5491
2024
Q3 		$78.6K Buy
9,746
+999
+11% +$9.36K ﹤0.01% 5151
2024
Q2 		$50.4K Sell
8,747
-54
-0.6% -$438 ﹤0.01% 5288
2024
Q1 		$105K Buy
8,801
+1
+0% +$11 ﹤0.01% 4866
2023
Q4 		$165K Buy
8,800
+9
+0.1% +$80 ﹤0.01% 4586
2023
Q3 		$83.4K Buy
8,791
+1
+0% +$12 ﹤0.01% 4887
2023
Q2 		$126K Buy
8,790
+6
+0.1% +$85 ﹤0.01% 4893
2023
Q1 		$135K Buy
8,784
+1
+0% +$16 ﹤0.01% 4661
2022
Q4 		$118K Buy
8,783
+1
+0% +$13 ﹤0.01% 4456
2022
Q3 		$121K Buy
8,782
+1
+0% +$13 ﹤0.01% 4508
2022
Q2 		$99K Buy
8,781
+4
+0% +$44 ﹤0.01% 4642
2022
Q1 		$117K Hold
8,777
– – ﹤0.01% 5239
2021
Q4 		$155K Sell
8,777
-1,000
-10% -$25.8K ﹤0.01% 5408
2021
Q3 		$310K Buy
9,777
+9,240
+1,721% +$531K ﹤0.01% 4909
2021
Q2 		$47K Buy
537
+512
+2,048% +$23.7K ﹤0.01% 5585
2021
Q1 		$1K Buy
25
+2
+9% +$43 ﹤0.01% 6681
2020
Q4 		$0 Hold
23
– – ﹤0.01% 6460
2020
Q3 		$0 Buy
+23
New +$123 ﹤0.01% 6302

Other funds holding ANVS

EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Wells Fargo's ANVS Position: Q2 2026 in Review

Wells Fargo increased its Annovis Bio (ANVS) stake by 112% in Q2 2026, buying an estimated $31.1K and bringing the position to 30,307 shares worth $56.4K. The position accounts for ﹤0.01% of the portfolio, ranked #5686.

Wells Fargo first reported a position in ANVS in Q3 2020 and has held it in 24 quarters since. The position peaked at $310K in Q3 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

  • Wells Fargo held 30,307 shares of Annovis Bio worth $56.4K as of Q2 2026.
  • Wells Fargo bought 16,000 Annovis Bio shares in Q2 2026, an estimated $31.1K.
  • Annovis Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5686 holding.
  • Wells Fargo first reported a position in Annovis Bio in Q3 2020 and has held it in 24 quarters since.
  • Wells Fargo's Annovis Bio position peaked at $310K in Q3 2021.
  • 61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.